Home / Root Platform / Masimo LiDCO
Masimo LiDCO
Masimo LiDCO®
Masimo LiDCO provides the PulseCO® algorithm for beat-to-beat advanced hemodynamic monitoring to support informed decision-making in high-acuity care areas such as the Operating Room.
- Uses existing arterial line and blood pressure transducer to monitor hemodynamic parameters
- The LiDCO algorithm converts beat-to-beat blood pressure into its constituent parts, flow and resistance, scaled to each patient’s age, height, and weight.
- Reliable on patients on vasoactive drugs1
Parameters and Indicators
Parameters and Indicators
The beat–to–beat parameters offers immediate feedback about a patient’s fluid and hemodynamic status.
The PulseCO algorithm in Masimo LiDCO calculates a variety of parameters including:
- Stroke Volume (SV): The amount of blood pumped by the left ventricle of the heart in one contraction
- Cardiac Output (CO): The amount of blood the heart pumps through the circulatory system in a minute, calculated by multiplying the stroke volume by the patient’s heart rate
- Systemic Vascular Resistance (SVR): The resistance to flow, calculated as the quotient of pressure and cardiac output
- Oxygen Delivery (DO2): The amount of oxygen delivered to the tissues, calculated as the product of cardiac output and oxygen concentration
- Stroke Volume Variation (SVV): The variation in stroke volume across at least one respiratory cycle; a dynamic variable that can predict fluid responsiveness in mechanically ventilated patients
- Pulse Pressure Variation (PPV): The variation in arterial pulse pressure across at least one respiratory cycle; like SVV, a dynamic variable that can predict fluid responsiveness in mechanically ventilated patients
Clinical Evidence
Clinical Evidence
Reductions in Postoperative Complications and Costs
- In a randomized, controlled trial of 743 patients undergoing major abdominal surgery, researchers found hemodynamic optimization with LiDCO led to a 15.7% reduction in postoperative complication rates2 and, as a result, patients monitored with LiDCO were on average $530 less expensive to treat than control patients who were not monitored.3
Reductions in 30-Day and 180-Day Mortality
- In a study comparing the outcomes of 600 emergency laparotomy patients, researchers found that, following the implementation of a program including LiDCO technology, there was a significant decrease in mortality at 30 days (from 21.8% to 15.5%) and 180 days (from 29.5% to 22.2%).4
Easy Setup and Operation
Easy Setup and Operation
Masimo LiDCO is designed for efficient setup and simple operation, with an intuitive, easy-to-interpret display:
- Plug-and-play operation using the invasive blood pressure output port on the third-party patient monitor
- Monitor using the existing blood pressure transducer, eliminating the need for an additional disposable
Key Features of LiDCO on Masimo Root® Display Monitor
Key Features of LiDCO on Masimo Root® Display Monitor
Automating Clinical Protocols
Automating Clinical Protocols
Step-by-Step Guided Protocols
Masimo LiDCO automates established clinical protocols, such as a Fluid Challenge Guided Protocol, a Passive Leg Raise Guided Protocol and an End- Expiratory Occlusion Test Guided Protocol.
Example: Guided Protocol Menu
Before the protocol begins, the initializing screen indicates that Masimo LiDCO is getting ready to provide data.
While the guided protocol is in progress, current and baseline data are displayed, along with a timer to measure progression of the protocol.
Upon the completion of the protocol, Masimo LiDCO calculates the change from baseline to completion, and provides a result. The Result screen displays the Starling Curve along with the results message.
References:
- 1.
Hadian, M et al. Critical Care. 2010 Dec;14(6):1-0.
- 2.
Pearse R et al. JAMA 2014; 311(21):2181-90.
- 3.
Sadique et al. Perioperative Medicine (2015) 4:13
- 4.
Tengberg LT et al. Br J Surg 2017; 104:463-471.
RESOURCES
Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings and precautions.
PLCO-006916/PLM-14500B-1023